FY2019 EPS Estimates for Orthofix International N.V. (NASDAQ:OFIX) Raised by Analyst
Orthofix International N.V. (NASDAQ:OFIX) – Research analysts at Gabelli raised their FY2019 earnings estimates for shares of Orthofix International N.V. in a research report issued on Wednesday. Gabelli analyst J. Tsai now anticipates that the medical device company will post earnings of $1.90 per share for the year, up from their previous forecast of $1.75.
OFIX has been the subject of several other reports. Zacks Investment Research downgraded Orthofix International N.V. from a “hold” rating to a “sell” rating in a research note on Tuesday, May 9th. Langenberg & Company reaffirmed a “buy” rating and issued a $53.25 price objective on shares of Orthofix International N.V. in a research note on Wednesday, June 14th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $55.00 price objective (up from $50.00) on shares of Orthofix International N.V. in a research note on Thursday. BidaskClub downgraded Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Finally, BTIG Research assumed coverage on Orthofix International N.V. in a research note on Wednesday, June 21st. They issued a “buy” rating and a $52.00 price objective for the company. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $52.75.
TRADEMARK VIOLATION NOTICE: “FY2019 EPS Estimates for Orthofix International N.V. (NASDAQ:OFIX) Raised by Analyst” was published by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.watchlistnews.com/fy2019-eps-estimates-for-orthofix-international-n-v-nasdaqofix-raised-by-analyst/1474033.html.
Shares of Orthofix International N.V. (OFIX) traded down 0.61% during mid-day trading on Friday, hitting $46.95. The stock had a trading volume of 74,562 shares. The stock has a 50 day moving average price of $45.63 and a 200-day moving average price of $40.81. The company has a market cap of $853.08 million, a PE ratio of 109.95 and a beta of 0.25. Orthofix International N.V. has a 52-week low of $32.51 and a 52-week high of $49.60.
Orthofix International N.V. (NASDAQ:OFIX) last issued its quarterly earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.01. The firm had revenue of $108.90 million for the quarter, compared to analyst estimates of $102.94 million. Orthofix International N.V. had a return on equity of 9.96% and a net margin of 1.88%. The business’s revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.41 earnings per share.
Institutional investors have recently added to or reduced their stakes in the stock. Pinebridge Investments L.P. increased its position in Orthofix International N.V. by 2.3% in the second quarter. Pinebridge Investments L.P. now owns 2,378 shares of the medical device company’s stock valued at $111,000 after buying an additional 53 shares during the last quarter. Mason Street Advisors LLC bought a new stake in shares of Orthofix International N.V. during the first quarter worth approximately $159,000. State of Alaska Department of Revenue boosted its stake in shares of Orthofix International N.V. by 79.3% in the second quarter. State of Alaska Department of Revenue now owns 3,551 shares of the medical device company’s stock worth $165,000 after buying an additional 1,571 shares during the period. Quantbot Technologies LP bought a new stake in shares of Orthofix International N.V. during the first quarter worth approximately $175,000. Finally, BNP Paribas Arbitrage SA boosted its stake in shares of Orthofix International N.V. by 68.9% in the first quarter. BNP Paribas Arbitrage SA now owns 4,656 shares of the medical device company’s stock worth $178,000 after buying an additional 1,900 shares during the period. 99.68% of the stock is owned by hedge funds and other institutional investors.
About Orthofix International N.V.
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.